Cargando…

SARS-CoV-2 incidence and vaccine escape

Detalles Bibliográficos
Autores principales:	Thompson, Robin N, Hill, Edward M, Gog, Julia R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043582/ https://www.ncbi.nlm.nih.gov/pubmed/33861968 http://dx.doi.org/10.1016/S1473-3099(21)00202-4

Ejemplares similares

Vaccine escape in a heterogeneous population: insights for SARS-CoV-2 from a simple model
por: Gog, Julia R., et al.
Publicado: (2021)

Rapid genome sequencing in hospitals to identify potential vaccine-escape SARS-CoV-2 variants
por: Snell, Luke B, et al.
Publicado: (2021)

SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients
por: Scherer, Erin M., et al.
Publicado: (2022)

Increased immune escape of the new SARS-CoV-2 variant of concern Omicron
por: Hu, Jie, et al.
Publicado: (2022)

Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6
por: Hachmann, Nicole P., et al.
Publicado: (2022)

SARS CoV2 vaccine and aphasia
por: sookaromdee, Pathum, et al.
Publicado: (2021)

Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1
por: Miller, Jessica, et al.
Publicado: (2023)

Effect of Vaccination on Transmission of SARS-CoV-2
por: Shah, Anoop S.V., et al.
Publicado: (2021)

Hemophagocytic lymphohistiocytosis and SARS-CoV-2 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Post SARS-CoV-2 vaccination effluvium
por: Luu, Ngoc-Nhi C., et al.
Publicado: (2023)

SARS-CoV-2 vaccines and donor recruitment for FMT
por: Ianiro, Gianluca, et al.
Publicado: (2021)

Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5
por: Hachmann, Nicole P., et al.
Publicado: (2022)

Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents
por: White, Elizabeth M., et al.
Publicado: (2021)

A strategy for SARS-CoV-2 vaccination in Yemen
por: Nasser, Abdullah, et al.
Publicado: (2021)

Ophthalmologic compromise following SARS-CoV-2 vaccinations
por: Finsterer, Josef
Publicado: (2022)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

SARS-CoV-2 vaccination for patients with inflammatory bowel disease
por: Garrido, Hannah M Garcia, et al.
Publicado: (2021)

The proximal origin of SARS-CoV-2
por: Andersen, Kristian G., et al.
Publicado: (2020)

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

Bell's palsy and SARS-CoV-2 vaccines—an unfolding story
por: Cirillo, Nicola, et al.
Publicado: (2021)

SARS-CoV-2 vaccination related hyperthyroidism of Graves’ disease
por: Shih, Shyang-Rong, et al.
Publicado: (2022)

Transmissibility of SARS-CoV-2 among fully vaccinated individuals
por: Ko, Humphrey H T
Publicado: (2022)

Transmissibility of SARS-CoV-2 among fully vaccinated individuals
por: Knol, Mirjam J, et al.
Publicado: (2022)

Transmissibility of SARS-CoV-2 among fully vaccinated individuals
por: Franco-Paredes, Carlos
Publicado: (2022)

Tolerability and impact of SARS-CoV-2 vaccination in elite athletes
por: Hull, James H, et al.
Publicado: (2022)

Correspondence to: hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination
por: Sprute, Rosanne, et al.
Publicado: (2022)

Effect of Vaccination on Household Transmission of SARS-CoV-2 in England
por: Harris, Ross J., et al.
Publicado: (2021)

Breakthrough SARS-CoV-2 Infections in Prison after Vaccination
por: Brinkley-Rubinstein, Lauren, et al.
Publicado: (2021)

SARS-CoV-2 vaccination triggered Guillain-Barre syndrome
por: Scorza, Fulvio A, et al.
Publicado: (2022)

Development of Schamberg's disease after SARS‐CoV‐2 vaccination
por: Morimoto, Hiroki, et al.
Publicado: (2022)

SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3
por: Falsey, Ann R., et al.
Publicado: (2021)

Neuropathology associated with SARS-CoV-2 infection
por: Nasrallah, MacLean P, et al.
Publicado: (2021)

The natural thermal sensitivity of SARS-CoV-2
por: Stewart, Patrick D Shaw, et al.
Publicado: (2022)

Attitudes of vaccination service providers to the SARS-CoV-2 intranasal spray vaccine during the SARS-CoV-2 pandemic in China: A cross-sectional study
por: Cao, Yanlin, et al.
Publicado: (2023)

Seroresponse to SARS-CoV-2 Vaccines Among Maintenance Dialysis Patients
por: Hsu, Caroline M., et al.
Publicado: (2022)

Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine
por: Zeng, Guangting
Publicado: (2022)

Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons
por: Kissler, Stephen M., et al.
Publicado: (2021)

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2
por: Lodge, Archie
Publicado: (2020)

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2
por: Chauhan, Anil, et al.
Publicado: (2020)

Vaccinated Individuals With Prior COVID-19 Have Lower Risk of Incident SARS-CoV-2 Infection When Compared With Vaccinated Individuals Without Prior Infection
por: Kojima, N, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rr2t5aldv5os132rb5vitune5o